1. Triester SL,
Leighton JA,
Leontiadis GI,
et al.
A meta- analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn’s disease.
Am J Gastroenterol 2006;101(5): 954–964.
2. Langan RC,
Gotsch PB,
Krafczyk MA,
Skillinge DD.
Ul- cerative colitis: diagnosis and treatment.
Am Fam Physician 2007;76(9):1323–1330.
3. Furukawa A,
Saotome T,
Yamasaki M,
et al.
Cross-sectional imaging in CD.
RadioGraphics 2004;24(3):689–702.
4. Amzallag-Bellenger E,
Oudjit A,
Ruiz A,
Cadiot G,
Soyer PA,
Hoeffel CC.
Effectiveness of MR enterography for the assessment of small-bowel diseases beyond CD.
RadioGraph- ics 2012;32(5):1423–1444.
5. Scholz FJ,
Humphrey PE.
Crohn’s disease.
In: Levy AD,
Mortele KJ,
Yeh BM,
eds.
Gastrointestinal imaging.
Oxford,
England: Oxford University Press,
2015; 136–141.
6. Wilkins T,
Jarvis K,
Patel J.
Diagnosis and management of Crohn’s disease.
Am Fam Physician 2011;84(12): 1365–1375.
7. Crohn BB,
Ginzburg L,
Oppenheimer GD.
Regional ileitis: a pathologic and clinical entity.
J Am Med Assoc 1932;99(16):1323–1329.
8. Sands BE,
Siegel CA.
Crohn’s disease.
In: Feldman M,
Friedman LS,
Brandt LJ,
eds.
Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology,
diagnosis,
management.
10th ed.
Philadelphia,
Pa: Elsevier Health Sci- ences,
2015; 1990–2022.
9. Gore RM,
Berlin JW,
Ivanovic AM.
Ulcerative and granu- lomatous colitis: idiopathic in ammatory bowel disease.
In: Gore RM,
Levine MS,
eds.
Textbook of gastrointes- tinal radiology.
4th ed.
Philadelphia,
Pa: Elsevier: 2015; 984–1016.
10.
Ephgrave K.
Extra-intestinal manifestations of Crohn’s disease.
Surg Clin North Am 2007;87(3):673–680.
11.
Maglinte DD,
Gourtsoyiannis N,
Rex D,
Howard TJ,
Kelvin FM.
Classi cation of small bowel Crohn’s subtypes based on multimodality imaging.
Radiol Clin North Am 2003;41(2):285–303.
12.
Louis E,
Collard A,
Oger AF,
Degroote E,
Aboul Nasr El Ya FA,
Belaiche J.
Behaviour of Crohn’s disease according to the Vienna classi cation: changing pattern over the course of the disease.
Gut 2001;49(6):777–782.
13.
Burke JP,
Mulsow JJ,
O’Keane C,
Docherty NG,
Watson RW,
O’Connell PR.
Fibrogenesis in Crohn’s disease.
Am J Gastroenterol 2007;102(2):439–448.
14.
Liu JK,
Lichtenstein GR.
In ammatory bowel disease.
In: Ginsberg GG,
Gostout CJ,
Kochman ML,
Norton ID,
eds.
Clinical gastrointestinal endoscopy.
2nd ed.
St Louis,
Mo: Elsevier Saunders,
2012; 243–264.
15.
24.
Sinha R,
Rajiah P,
Murphy P,
Hawker P,
Sanders S.
Utility of high-resolution MR imaging in demonstrating transmural pathologic changes in CD.
RadioGraphics 2009;29(6): 1847–1867.
16.
25.
Sempere GA,
Martinez Sanjuan V,
Medina Chulia E,
et al.
MRI evaluation of in ammatory activity in Crohn’s disease.
AJR Am J Roentgenol 2005;184(6):1829–1835.
17.
26.
Punwani S,
Rodriguez-Justo M,
Bainbridge A,
et al.
Mural in ammation in CD: location-matched histologic valida- tion of MR imaging features.
Radiology 2009;252(3): 712–720.
18.
Rimola J,
Planell N,
Rodríguez S,
et al.
Characterization of in ammation and brosis in Crohn’s disease lesions by magnetic resonance imaging.
Am J Gastroenterol 2015;110(3):432–440.
19.
Carbo AI,
Reddy T,
Gates T,
Vesa T,
Thomas J,
Gonzalez E.
The most characteristic lesions and radiologic signs of CD of the small bowel: air enteroclysis,
MDCT,
endoscopy,
and pathology.
Abdom Imaging 2014;39(1):215–234.
20.
Herlinger H,
Furth EE,
Rubesin SE.
Fibrofatty prolifera- tion of the mesentery in CD.
Abdom Imaging 1998;23(4): 446–448.
21.
Tielbeek JA,
Makanyanga JC,
Bipat S,
et al.
Grading CD activity with MRI: interobserver variability of MRI features,
MRI scoring of severity,
and correlation with CD endoscopic index of severity.
AJR Am J Roentgenol 2013;201(6):1220–1228.
22.
Cosnes J,
Cattan S,
Blain A,
et al.
Long-term evolution of disease behavior of Crohn’s disease.
In amm Bowel Dis 2002;8(4):244–250.
23.
Li C,
Kuemmerle JF.
Mechanisms that mediate the develop- ment of brosis in patients with Crohn’s disease.
In amm Bowel Dis 2014;20(7):1250–1258.
24.
Siegel CA.
Risk of lymphoma in in ammatory bowel disease.
Gastroenterol Hepatol (N Y) 2009;5(11):784–790.
25.
Wilks S.
Morbid appearances in the intestines of Miss Bankes.
Med Times Gaz 1859;2:264–265.
26.
Osterman MT,
Lichtenstein GR.
Ulcerative colitis.
In: Brandt LJ,
Feldman M,
Friedman LS,
eds.
Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology,
diagnosis,
management.
10th ed.
Philadelphia,
Pa: Elsevier Health Sciences,
2015; 2023–2061.
27.
Adams SM,
Bornemann PH.
Ulcerative colitis.
Am Fam Physician 2013;87(10):699–705.
28.
Gore RM,
Balthazar EJ,
Ghahremani GG,
Miller FH.
CT features of ulcerative colitis and Crohn’s disease.
AJR Am J Roentgenol 1996;167(1):3–15.
29.
Laghi A,
Paolantonio P,
Iafrate F,
Altomari F,
Miglio C,
Passariello R.
Oral contrast agents for magnetic resonance imaging of the bowel.
Top Magn Reson Imaging 2002;13:389–396.
30.
Rieber A,
Aschoff A,
Nussle K,
et al.
MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis.
Eur Radiol 2000;10:1377–1382.